Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05240651 · ClinicalTrials.gov registry record
Change in Stroke Volume Index After Diuresis for Patients With Decompensated Heart Failure
A clinical trial of Acute Decompensated Heart Failure, sponsored by NYU Langone Health.
- Recruiting
- Registry status
- 50
- Enrollment target
- 1
- Study location
NCT05240651: Recruiting study of Acute Decompensated Heart Failure, sponsored by NYU Langone Health.
NCT05240651 is a study of Acute Decompensated Heart Failure that is actively recruiting participants, run by NYU Langone Health. The registered enrollment target is 50 participants, below the 455-participant average among 12 other Acute Decompensated Heart Failure trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05240651, a study of Acute Decompensated Heart Failure, is actively recruiting participants, sponsored by NYU Langone Health.
- RECRUITING
- Registry status
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a prospective cohort study for 50 patients admitted to the cardiac care unit requiring clinically-indicated diuretic therapy for congestive heart failure. The purpose of this study is to assess the role of non-invasive cardiac output monitoring (NICOM) with the Starling Fluid Management System (Baxter Medical, Deerfield, IL) in determining volume status in patients with acute decompensated heart failure requiring intravenous diuretic therapy.
Conditions Studied
Study Locations (1)
New York
- NYU Langone Health - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2022-08-30 |
| Est. Completion | 2026-07-01 |
What NCT05240651 shows while recruiting
NCT05240651 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 455-participant average among 12 other Acute Decompensated Heart Failure trials with a reported enrollment target (89% lower).
The record links to 1 condition, with Acute Decompensated Heart Failure appearing as the primary indexed condition, and to 0 interventions.
NCT05240651 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT05240651 about?
NCT05240651 is a clinical study titled "Change in Stroke Volume Index After Diuresis for Patients With Decompensated Heart Failure". This is a prospective cohort study for 50 patients admitted to the cardiac care unit requiring clinically-indicated diuretic therapy for congestive heart failure. The purpose of this study is to assess the role of non-invasive cardiac output monitoring (NICOM) with the Starling Fluid Management Syst...
What is the current status of trial NCT05240651?
This trial is currently recruiting. The enrollment target is 50 participants. The study started on 2022-08-30. Estimated completion is 2026-07-01.
What conditions does trial NCT05240651 study?
This clinical trial studies the following conditions: Acute Decompensated Heart Failure.
Who is sponsoring clinical trial NCT05240651?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05240651 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Decompensated Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05240651's enrollment target sits among peer trials
50 9th of 12 higher than 4 of 12 other Acute Decompensated Heart Failure trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Acute Decompensated Heart Failure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Circulating Markers That Underlie the Transition From Compensated Hypertrophy to Heart Failure
RECRUITING
-
Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve System (FASTR-II) (IDE-G210258)
RECRUITING · Phase 3
-
Low Level Tragus Stimulation in Acute Decompensated Heart Failure
RECRUITING · NA
-
IC14 for Treatment of Acute Decompensated Heart Failure
ACTIVE NOT RECRUITING · Phase 1
-
DORAYA-HF Early Feasibility Study
ACTIVE NOT RECRUITING · NA
-
Use of the Impella BTR™ in Patients With Heart Failure: An Early Feasibility Study
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI